Literature DB >> 26599623

A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.

Eliza L S Fong1, Xinhai Wan2, Jun Yang2, Micaela Morgado3, Antonios G Mikos1, Daniel A Harrington3, Nora M Navone4, Mary C Farach-Carson5.   

Abstract

Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. However, the complex in vivo environment makes it challenging to employ PDX models to investigate tumor-stromal interactions, such as those that mediate prostate cancer (PCa) bone metastasis. Thus, we engineered a defined three-dimensional (3D) hydrogel system capable of supporting the co-culture of PCa PDX cells and osteoblastic cells to recapitulate the PCa-osteoblast unit within the bone metastatic microenvironment in vitro. Our 3D model not only maintained cell viability but also preserved the typical osteogenic phenotype of PCa PDX cells. Additionally, co-culture cellularity was maintained over that of either cell type cultured alone, suggesting that the PCa-osteoblast cross-talk supports PCa progression in bone, as is hypothesized to occur in patients with prostatic bone metastasis. Strikingly, osteoblastic cells co-cultured with PCa PDX tumoroids organized around the tumoroids, closely mimicking the architecture of PCa metastases in bone. Finally, tumor-stromal signaling mediated by the fibroblast growth factor axis tightly paralleled that in the in vivo counterpart. Together, these findings indicate that this 3D PCa PDX model recapitulates important pathological properties of PCa bone metastasis, and validate the use of this model for controlled and systematic interrogation of complex in vivo tumor-stromal interactions.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Co-culture; Hydrogel; Model; Osteoblasts; Patient-derived xenograft; Prostate cancer; Three-dimensional

Mesh:

Substances:

Year:  2015        PMID: 26599623      PMCID: PMC4684431          DOI: 10.1016/j.biomaterials.2015.10.059

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  36 in total

1.  Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics.

Authors:  M P Lutolf; J L Lauer-Fields; H G Schmoekel; A T Metters; F E Weber; G B Fields; J A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-09       Impact factor: 11.205

2.  FGFR1 and the bloodline of the vasculature.

Authors:  Victor W M van Hinsbergh; Ton J Rabelink
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-05       Impact factor: 8.311

3.  Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.

Authors:  J Yang; K Fizazi; S Peleg; C R Sikes; A K Raymond; N Jamal; M Hu; M Olive; L A Martinez; C G Wood; C J Logothetis; G Karsenty; N M Navone
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

Review 4.  Osteoblasts in prostate cancer metastasis to bone.

Authors:  Christopher J Logothetis; Sue-Hwa Lin
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

5.  Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Authors:  Yi Lu; Jian Zhang; Jinlu Dai; Lindsay A Dehne; Atsushi Mizokami; Zhi Yao; Evan T Keller
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  FGF-8 is involved in bone metastasis of prostate cancer.

Authors:  Maija P Valta; Johanna Tuomela; Anders Bjartell; Eeva Valve; H Kalervo Väänänen; Pirkko Härkönen
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

7.  Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.

Authors:  Karim Fizazi; Jun Yang; Sara Peleg; Charles R Sikes; Erica L Kreimann; Danai Daliani; Matilde Olive; Kevin A Raymond; Todd J Janus; Christopher J Logothetis; Gerard Karsenty; Nora M Navone
Journal:  Clin Cancer Res       Date:  2003-07       Impact factor: 12.531

8.  Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.

Authors:  Zhi Gang Li; Paul Mathew; Jun Yang; Michael W Starbuck; Amado J Zurita; Jie Liu; Charles Sikes; Asha S Multani; Eleni Efstathiou; Adriana Lopez; Jing Wang; Tina V Fanning; Victor G Prieto; Vikas Kundra; Elba S Vazquez; Patricia Troncoso; Austin K Raymond; Christopher J Logothetis; Sue-Hwa Lin; Sankar Maity; Nora M Navone
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

9.  Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.

Authors:  Panayiotis Loukopoulos; Kengo Kanetaka; Masaaki Takamura; Tatsuhiro Shibata; Michiie Sakamoto; Setsuo Hirohashi
Journal:  Pancreas       Date:  2004-10       Impact factor: 3.327

10.  Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.

Authors:  K Sahadevan; S Darby; H Y Leung; M E Mathers; C N Robson; V J Gnanapragasam
Journal:  J Pathol       Date:  2007-09       Impact factor: 7.996

View more
  33 in total

Review 1.  Cellular determinants and microenvironmental regulation of prostate cancer metastasis.

Authors:  Kiera Rycaj; Hangwen Li; Jianjun Zhou; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2017-04-11       Impact factor: 15.707

Review 2.  Heralding a new paradigm in 3D tumor modeling.

Authors:  Eliza L S Fong; Daniel A Harrington; Mary C Farach-Carson; Hanry Yu
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

3.  Perlecan domain I gradients establish stable biomimetic heparin binding growth factor gradients for cell migration in hydrogels.

Authors:  Kelsea M Hubka; Daniel D Carson; Daniel A Harrington; Mary C Farach-Carson
Journal:  Acta Biomater       Date:  2019-07-24       Impact factor: 8.947

4.  Three-Dimensional Mechanical Loading Modulates the Osteogenic Response of Mesenchymal Stem Cells to Tumor-Derived Soluble Signals.

Authors:  Maureen E Lynch; Aaron E Chiou; Min Joon Lee; Stephen C Marcott; Praveen V Polamraju; Yeonkyung Lee; Claudia Fischbach
Journal:  Tissue Eng Part A       Date:  2016-08-01       Impact factor: 3.845

5.  Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel.

Authors:  Mai T Ngo; Brendan A C Harley
Journal:  Biomaterials       Date:  2018-06-13       Impact factor: 12.479

Review 6.  Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling.

Authors:  Pradip Shahi Thakuri; Chun Liu; Gary D Luker; Hossein Tavana
Journal:  Adv Healthc Mater       Date:  2017-12-04       Impact factor: 9.933

7.  Development of a 3D bone marrow adipose tissue model.

Authors:  Heather Fairfield; Carolyne Falank; Mariah Farrell; Calvin Vary; Joshua M Boucher; Heather Driscoll; Lucy Liaw; Clifford J Rosen; Michaela R Reagan
Journal:  Bone       Date:  2018-01-31       Impact factor: 4.398

Review 8.  The potential of organoids in urological cancer research.

Authors:  Shangqian Wang; Dong Gao; Yu Chen
Journal:  Nat Rev Urol       Date:  2017-05-23       Impact factor: 14.432

9.  Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocols.

Authors:  Ushashi Dadwal; Carolyne Falank; Heather Fairfield; Sarah Linehan; Clifford J Rosen; David L Kaplan; Julie Sterling; Michaela R Reagan
Journal:  Bonekey Rep       Date:  2016-10-19

10.  Multidimensional hydrogel models reveal endothelial network angiocrine signals increase glioblastoma cell number, invasion, and temozolomide resistance.

Authors:  Mai T Ngo; Elijah Karvelis; Brendan A C Harley
Journal:  Integr Biol (Camb)       Date:  2020-06-19       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.